EP1185286A4 - MU O-CONOPEPTIDE AND THEIR USE AS A LOCAL ANESTHETIC - Google Patents

MU O-CONOPEPTIDE AND THEIR USE AS A LOCAL ANESTHETIC

Info

Publication number
EP1185286A4
EP1185286A4 EP00939692A EP00939692A EP1185286A4 EP 1185286 A4 EP1185286 A4 EP 1185286A4 EP 00939692 A EP00939692 A EP 00939692A EP 00939692 A EP00939692 A EP 00939692A EP 1185286 A4 EP1185286 A4 EP 1185286A4
Authority
EP
European Patent Office
Prior art keywords
conopeptide
local anesthetic
anesthetic
local
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00939692A
Other languages
German (de)
French (fr)
Other versions
EP1185286A1 (en
Inventor
Baldomero M Olivera
J Michael Mcintosh
R Tyler Mccabe
James E Garrett
Richard T Layer
John D Wagstaff
Robert M Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognetix Inc
University of Utah Research Foundation Inc
Original Assignee
Cognetix Inc
University of Utah Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognetix Inc, University of Utah Research Foundation Inc filed Critical Cognetix Inc
Publication of EP1185286A1 publication Critical patent/EP1185286A1/en
Publication of EP1185286A4 publication Critical patent/EP1185286A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP00939692A 1999-06-10 2000-06-09 MU O-CONOPEPTIDE AND THEIR USE AS A LOCAL ANESTHETIC Withdrawn EP1185286A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13850799P 1999-06-10 1999-06-10
US138507P 1999-06-10
PCT/US2000/015779 WO2000076532A1 (en) 1999-06-10 2000-06-09 νO-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHETICS

Publications (2)

Publication Number Publication Date
EP1185286A1 EP1185286A1 (en) 2002-03-13
EP1185286A4 true EP1185286A4 (en) 2004-09-08

Family

ID=22482336

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00939692A Withdrawn EP1185286A4 (en) 1999-06-10 2000-06-09 MU O-CONOPEPTIDE AND THEIR USE AS A LOCAL ANESTHETIC

Country Status (5)

Country Link
EP (1) EP1185286A4 (en)
JP (1) JP2003501109A (en)
AU (1) AU5474200A (en)
CA (1) CA2376357A1 (en)
WO (1) WO2000076532A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2396529A1 (en) 1999-12-30 2001-07-12 University Of Utah Research Foundation O-superfamily conotoxin peptides
GB0011202D0 (en) * 2000-05-09 2000-06-28 Kci Licensing Inc Abdominal wound dressing
WO2002007756A1 (en) * 2000-07-20 2002-01-31 Cognetix, Inc. MuO-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHETICS
WO2002007678A2 (en) * 2000-07-21 2002-01-31 University Of Utah Research Foundation Mu-conopeptides
CA2661014A1 (en) * 2006-08-17 2008-02-21 Eribis Pharmaceuticals Ab Cardioprotective compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719264A (en) * 1994-10-07 1998-02-17 Univ. Of Utah Research Foundation Conotoxin peptides
FR2785613A1 (en) * 1998-11-10 2000-05-12 Commissariat Energie Atomique New conotoxin, useful for treating neurodegenerative disorders, e.g. multiple sclerosis, have selective presynaptic action on neuronal sodium channels

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2216751A1 (en) * 1995-04-17 1996-10-24 Doju Yoshikami Conotoxin peptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719264A (en) * 1994-10-07 1998-02-17 Univ. Of Utah Research Foundation Conotoxin peptides
FR2785613A1 (en) * 1998-11-10 2000-05-12 Commissariat Energie Atomique New conotoxin, useful for treating neurodegenerative disorders, e.g. multiple sclerosis, have selective presynaptic action on neuronal sodium channels

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BAI-SONG L ET AL: "CONOPEPTIDES FROM CONUS STRIATUS AND CONUS TEXTILE BY CDNA CLONING", PEPTIDES, ELMSFORD, US, vol. 20, 1999, pages 1139 - 1144, XP002939062, ISSN: 0196-9781 *
FAINZILBER M ET AL: "NEW SODIUM CHANNEL-BLOCKING CONOTOXINS ALSO AFFECT CALCIUM CURRENTSIN LYMNAEA NEURONS", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, vol. 34, no. 16, 25 April 1995 (1995-04-25), pages 5364 - 5371, XP002061899, ISSN: 0006-2960 *
See also references of WO0076532A1 *
TERLAU HEINRICH ET AL: "Mu-O-conotoxin MrVIA inhibits mammalian sodium channels, but not through site I", JOURNAL OF NEUROPHYSIOLOGY (BETHESDA), vol. 76, no. 3, 1996, pages 1423 - 1429, XP009034053, ISSN: 0022-3077 *

Also Published As

Publication number Publication date
EP1185286A1 (en) 2002-03-13
AU5474200A (en) 2001-01-02
JP2003501109A (en) 2003-01-14
CA2376357A1 (en) 2000-12-21
WO2000076532A1 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
DE59803292D1 (en) TRIAZOLIC COMPOUNDS AND THEIR USE AS DOPAMIN-D 3-LIGANDS
DE60001840D1 (en) CHINUCLIDIN DERIVATIVES AND THEIR USE AS MUSCARIN M3 RECEPTOR LIGANDS
DE60045321D1 (en) Mutilin derivatives and their use as antimicrobial agents
DE60027479D1 (en) RESIN STRUCTURE AND ITS USE
DE60034713D1 (en) Quinolyl-propyl-piperidine derivatives and their use as antimicrobial agents
DE50111690D1 (en) 2-ACYL-INDOLDERIVATE AND THEIR USE AS ANTITUM-MEANS
DE60113719D1 (en) CHINUCLIDINCARBAMATE DERIVATIVES AND THEIR USE AS M3 ANTAGONISTS
ATE298337T1 (en) NEW USE AND NEW N-AZABICYCLOAMIDE COMPOUNDS
DE60036803D1 (en) ARYLMETHYL-CARBONYLAMINO-THIAZONE DERIVATIVES AND THEIR USE AS ANTITUM-MEANS
ATE302193T1 (en) BENZOHETEROCYCLES AND THEIR USE AS MEK INHIBITORS
PT1204663E (en) NEW ESPIRO COMPOUNDS WITH ANTAGONIST NEUROPEPTIDO ACTIVITY AND
DE60105859D1 (en) Urazil connections and their use
ATE273301T1 (en) SUBSTITUTED AZA AND DIAZACYCLOHEPTAN AND CYCLOOCTANE COMPOUNDS AND USE THEREOF
ATE260033T1 (en) BIOCIDAL COMPOSITION AND USE THEREOF
DE60104776D1 (en) Diphenylurea derivatives and their use as alpha2 / 5-HT2c antagonists
DE60027927D1 (en) RESIN STRUCTURE AND ITS USE
DE60114413D1 (en) SUBSTITUTED 1-AMINOALKYL-LACTAME AND THEIR USE AS MUSCARIN RECEPTOR ANTAGONISTS
ATE364575T1 (en) ZEOLITE AND THEIR USE
DE60021507D1 (en) Uracil compounds and their use
DE50011452D1 (en) POLYALKENALKOHOL-POLYALKOXYLATE AND THEIR USE IN FORCE AND LUBRICANTS
DE50008549D1 (en) TRIAZOLOTRIAZINONE AND THEIR USE
ATE215061T1 (en) ((3-ALKOXY-PHENOXY)-ETHYL)-DIALKYLAMINE DERIVATIVES AND THEIR USE AS LOCAL ANESTHETICS
ATE250339T1 (en) DORMANCY-BREAKING COMPOSITION AND USE THEREOF
DE60013191D1 (en) Surfactant composition and its use
DE59906951D1 (en) SPIRO CONNECTIONS AND THEIR USE

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011221

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040728

17Q First examination report despatched

Effective date: 20050704

17Q First examination report despatched

Effective date: 20050704

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070201